Top

Published in:

16-06-2023 | Phototherapy | Review

Emerging trends in combination strategies with phototherapy in advanced psoriasis management

Authors: Ratnam Sreya, Shweta Nene, Vrushali Pathade, Shashi Bala Singh, Saurabh Srivastava

Published in: Inflammopharmacology | Issue 4/2023

Abstract

Psoriasis is a non-contagious, chronic, relapsing inflammatory skin disease with cutaneous manifestations such as red, raised scaly plaques. Current treatment approaches for psoriasis comprise topical therapy, systemic therapy, phototherapy, psoralen with UVA(PUVA) and biologics. Regardless of the progression in therapeutic approaches (novel therapies like biologics) in psoriasis, phototherapy is also an economical, compelling and safe treatment option that lacks the immunosuppressive properties as well as the toxicities of traditional modalities. It can be combined safely with other therapeutic options such as topical therapies and novel biologics and provide effective therapy. The aim of the current review is to analyze the literature on the safety as well as the efficacy of phototherapy with various treatment modalities in the management of psoriasis. This review summarizes randomized controlled clinical trials addressing combinations of phototherapy with other treatment modalities for the management of psoriasis. The findings of these clinical studies are elaborated.

Graphical abstract

Afifi T, de Gannes G, Huang C, Zhou Y (2005) Topical therapies for psoriasis: evidence-based review. Can Fam Phys 51:519–525

Aggarwal P, Aggarwal K, Jain VK (2016) Tacalcitol: a useful adjunct to narrow band ultraviolet B phototherapy in psoriasis. J Dermatol Treat 27:546–551. https://doi.org/10.3109/09546634.2016.1163318CrossRef

Al-Hamamy HR, Al-Mashhadani SA, Mustafa IN (2014) Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis. Int J Dermatol 53:1531–1535. https://doi.org/10.1111/ijd.12444CrossRefPubMed

Arndt KA, Leboit PE, Wintroub BU, Stein Gold LF (2016) Topical therapies for psoriasis: improving management strategies and patient adherence (guest editor)

Bagel J, Nelson E, Keegan BR (2017) Apremilast and narrowband ultraviolet-B combination therapy for treating moderate-to-severe plaque psoriasis. J Drugs Dermatol 16:957–962PubMed

Bajaj S, Gautam RK, Khurana A et al (2017) Effect of narrow band ultraviolet B phototherapy on T helper 17 cell specific cytokines (interleukins-17, 22 and 23) in psoriasis vulgaris. J Dermatol Treat 28:14–17. https://doi.org/10.1080/09546634.2016.1177162CrossRef

Balak DMW (2014) Fumaric acid esters in the management of psoriasis. Psoriasis Targets Ther 5:9–23

Baliwag J, Barnes DH, Johnston A (2015) Cytokines in psoriasis. Cytokine 73:342–350CrossRefPubMedPubMedCentral

Batycka-Baran A, Besgen P, Wolf R et al (2016) The effect of phototherapy on systemic inflammatory process in patients with plaque psoriasis. J Photochem Photobiol B 161:396–401. https://doi.org/10.1016/j.jphotobiol.2016.05.023CrossRefPubMed

Buechler CR, Veenstra J, Stein Gold L (2021) New topical therapies for psoriasis. Dermatol Rev 2:262–268. https://doi.org/10.1002/der2.84CrossRef

Campbell J (2020) Safe and effective use of phototherapy and photochemotherapy in the treatment of psoriasis. Br J Nurs 29:547–552. https://doi.org/10.12968/bjon.2020.29.10.547CrossRefPubMed

Chen L, Shen Z (2020) Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders. Cell Mol Immunol 17:64–75CrossRefPubMed

Coates LC, Merola JF, Grieb SM et al (2020) Methotrexate in psoriasis and psoriatic arthritis. J Rheumatol 96:31–35. https://doi.org/10.3899/jrheum.200124CrossRef

Czarnecka-Operacz M, Sadowska-Przytocka A (2014) The possibilities and principles of methotrexate treatment of psoriasis—the updated knowledge. Postepy Dermatol Alergol 31:392–400. https://doi.org/10.5114/pdia.2014.47121CrossRefPubMedPubMedCentral

D’Arcy MS (2019) Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 43:582–592CrossRefPubMed

Dainichi T, Kitoh A, Otsuka A et al (2018) The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol 19:1286–1298CrossRefPubMed

Dayal S, Kaura R, Sahu P, Jain VK (2018) Tazarotene gel with narrow-band UVB phototherapy: a synergistic combination in psoriasis. An Bras Dermatol 93:385–390. https://doi.org/10.1590/abd1806-4841.20186723CrossRefPubMedPubMedCentral

Doppalapudi S, Jain A, Chopra DK, Khan W (2017) Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Eur J Pharm Sci 96:515–529. https://doi.org/10.1016/j.ejps.2016.10.025CrossRefPubMed

Dubois Declercq S, Pouliot R (2013) Promising new treatments for psoriasis. Sci World J. https://doi.org/10.1155/2013/980419CrossRef

Elmets CA, Lim HW, Stoff B et al (2019) Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol 81:775–804. https://doi.org/10.1016/j.jaad.2019.04.042CrossRefPubMed

Fletcher JM, Moran B, Petrasca A, Smith CM (2020) IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin Exp Immunol 201:121–134CrossRefPubMedPubMedCentral

Gagan Jot Kaur SBPSUKN (2023) Randomized double blinded placebo controlled comparative study of topical steroid plus bath PUVA versus bath PUVA and placebo cream. J Pak Assoc Dermatol

Gahalaut P, Soodan PS, Mishra N et al (2014) Clinical efficacy of psoralen + sunlight vs. combination of isotretinoin and psoralen + sunlight for the treatment of chronic plaque-type psoriasis vulgaris: a randomized hospital-based study. Photodermatol Photoimmunol Photomed 30:294–301. https://doi.org/10.1111/phpp.12125CrossRefPubMed

Ghiasi M, Ebrahimi S, Lajevardi V et al (2019) Efficacy and safety of pioglitazone plus phototherapy versus phototherapy in patients with plaque type psoriasis: a double blinded randomized controlled trial. J Dermatol Treat 30:664–667. https://doi.org/10.1080/09546634.2018.1544702CrossRef

Gnaneshwar Rao A, Jagadevapuram K (2021) Comparative study of PUVA and NB-UVB in the management of chronic plaque psoriasis. Indian J Drugs Dermatol 7:79. https://doi.org/10.4103/ijdd.ijdd_26_20CrossRef

Gomez C, Muangnoi C, Sorasitthiyanukarn FN et al (2019) Synergistic effects of photo-irradiation and curcumin-chitosan/alginate nanoparticles on tumor necrosis factor-alpha-induced psoriasis-like proliferation of keratinocytes. Molecules. https://doi.org/10.3390/molecules24071388CrossRefPubMedPubMedCentral

Gottlieb AB, Chao C, Dann F (2008) Psoriasis comorbidities. J Dermatol Treat 19:5–21CrossRef

Grzybowski A, Sak J, Pawlikowski J (2016) A brief report on the history of phototherapy. Clin Dermatol 34:532–537. https://doi.org/10.1016/j.clindermatol.2016.05.002CrossRefPubMed

Gudjonsson JE, Elder JT (2007) Psoriasis: epidemiology. Clin Dermatol 25:535–546. https://doi.org/10.1016/j.clindermatol.2007.08.007CrossRefPubMed

Hamm H, Wilsmann-Theis D, Tsianakas A et al (2021) Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate-to-severe plaque psoriasis: a randomized, double-blinded, placebo-controlled trial. Br J Dermatol 185:62–73. https://doi.org/10.1111/bjd.19747CrossRefPubMed

Hassan R, Ali S, Kallan F et al (2020) A study to compare the efficacy and safety of narrow band-UVB alone as well as in combination with topical calcipotriol in patients with psoriasis vulgaris. IP Indian J Clin Exp Dermatol 6:30–34. https://doi.org/10.18231/j.ijced.2020.008CrossRef

Ho AW, Kupper TS (2019) T cells and the skin: from protective immunity to inflammatory skin disorders. Nat Rev Immunol 19:490–502CrossRefPubMed

Hönigsmann H (2001) Phototherapy for psoriasis. Clin Exp Dermatol 26:343–350. https://doi.org/10.1046/j.1365-2230.2001.00828.xCrossRefPubMed

Hönigsmann H (2013) History of phototherapy in dermatology. Photochem Photobiol Sci 12:16–21CrossRefPubMed

Horn EJ, Domm S, Katz HI et al (2010) Topical corticosteroids in psoriasis: strategies for improving safety. J Eur Acad Dermatol Venereol 24:119–124CrossRefPubMed

Jain H, Bhat AR, Dalvi H et al (2021) Repurposing approved therapeutics for new indication: addressing unmet needs in psoriasis treatment. Curr Res Pharmacol Drug Discov 2:100041CrossRefPubMedPubMedCentral

Jankowiak Beata Kowalewska El B, Krajewska-Kułak Dzmitry Khvorikzbieta F (2020) Stigmatization and quality of life in patients with psoriasis. Dermatol Ther. https://doi.org/10.6084/m9.figshare.11890032

Jyothi SL, Krishna KL, Ameena Shirin VK et al (2021) Drug delivery systems for the treatment of psoriasis: current status and prospects. J Drug Deliv Sci Technol 62:106324

Kamata M, Tada Y (2018) Safety of biologics in psoriasis. J Dermatol 45:279–286CrossRefPubMed

Kaushik SB, Lebwohl MG (2019) Review of safety and efficacy of approved systemic psoriasis therapies. Int J Dermatol 58:649–658CrossRefPubMed

Khadka DK, Agrawal S, Dhali TK (2016) Methotrexate plus narrow band ultraviolet B (NBUVB) versus methotrexate alone in the treatment of moderate to severe plaque psoriasis: a randomized clinical trial. Nepal J Dermatol Venereol Leprol 13:12–23. https://doi.org/10.3126/njdvl.v13i1.14298CrossRef

Kim WB, Jerome D, Yeung J (2017) Diagnosis and management of psoriasis. Can Fam Phys 63:278–285

Koo JYM, Lowe NJ, Lew-Kaya DA et al (2000) Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol 43:821–828. https://doi.org/10.1067/mjd.2000.107940CrossRefPubMed

Kwan Z, Bong YB, Tan LL et al (2018) Determinants of quality of life and psychological status in adults with psoriasis. Arch Dermatol Res 310:443–451. https://doi.org/10.1007/s00403-018-1832-xCrossRefPubMed

Laws PM, Young HS (2010) Topical treatment of psoriasis. Expert Opin Pharmacother 11:1999–2009CrossRefPubMed

Lebwohl M, Ali S (2001) Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 45:649–664. https://doi.org/10.1067/mjd.2001.117047CrossRefPubMed

Lee CH, Wu SB, Hong CH et al (2013) Molecular mechanisms of UV-induced apoptosis and its effects on skin residential cells: the implication in UV-based phototherapy. Int J Mol Sci 14:6414–6435. https://doi.org/10.3390/ijms14036414CrossRefPubMedPubMedCentral

Lee HJ, Hong YJ, Kim M (2021) Angiogenesis in chronic inflammatory skin disorders. Int J Mol Sci 22:169

Levin E, Debbaneh M, Malakouti M et al (2015) Supraerythemogenic excimer laser in combination with clobetasol spray and calcitriol ointment for the treatment of generalized plaque psoriasis: interim results of an open label pilot study. J Dermatol Treat 26:16–18. https://doi.org/10.3109/09546634.2013.860210CrossRef

Lin X, Meng X, Song Z, Lin J (2022) Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry. Mol Cell Biochem 477:1905–1920. https://doi.org/10.1007/s11010-022-04417-0CrossRefPubMed

Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866–873CrossRefPubMed

Lowes MA, Suárez-Fariñas M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32:227–255CrossRefPubMedPubMedCentral

Lynch M, Tobin AM, Ahern T et al (2014a) Sitagliptin for severe psoriasis. Clin Exp Dermatol 39:841–842CrossRefPubMed

Lynch M, Ahern TB, Timoney I et al (2016) Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial. Trials. https://doi.org/10.1186/s13063-016-1157-zCrossRefPubMedPubMedCentral

Mahajan R, Kaur I, Kanwar A (2010) Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis—a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol 24:595–600. https://doi.org/10.1111/j.1468-3083.2009.03486.xCrossRefPubMed

Matz H (2010) Phototherapy for psoriasis: what to choose and how to use: facts and controversies. Clin Dermatol 28:73–80. https://doi.org/10.1016/j.clindermatol.2009.04.003CrossRefPubMed

Morita A (2018) Current developments in phototherapy for psoriasis. J Dermatol 45:287–292CrossRefPubMed

Mrowietz U (2001) Advances in systemic therapy for psoriasis. Clin Exp Dermatol 26:362–367. https://doi.org/10.1046/j.1365-2230.2001.00835.xCrossRefPubMed

Nadia A, Elsherif 1 IMESAE-D (2015) Narrow band UVB monotherapy versus topical calcipotriol ointment combined with narrow band UVB phototherapy for treatment of psoriasis vulgaris. Ibnosina J Med Biomed Sci

Naldi L, Gambini D (2007) The clinical spectrum of psoriasis. Clin Dermatol 25:510–518. https://doi.org/10.1016/j.clindermatol.2007.08.003CrossRefPubMed

Nast A, Boehncke W-H, Mrowietz U et al (2012) S3-Guidelines on the treatment of psoriasis vulgaris (English version). Update guidelines on the treatment of psoriasis vulgaris S1 1 preface. JDDG. https://doi.org/10.1111/j.1610-0379.2012.07919.x

Neimann AL, Porter SB, Gelfand JM (2006a) The epidemiology of psoriasis. Expert Rev Dermatol 1:63–75. https://doi.org/10.1586/17469872.1.1.63CrossRef

Neimann AL, Shin DB, Wang X et al (2006b) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835. https://doi.org/10.1016/j.jaad.2006.08.040CrossRefPubMed

Nejad SB, Ghadim HH, Ezzati A et al (2015) Comparison between the effects of Daivonex cream alone and its combination with narrowband ultraviolet B in treatment of psoriasis. Our Dermatol Online. https://doi.org/10.7241/ourd.20153.76CrossRef

Norval M (2006) The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog Biophys Mol Biol 92:108–118CrossRefPubMed

Ogawa E, Sato Y, Minagawa A, Okuyama R (2018) Pathogenesis of psoriasis and development of treatment. J Dermatol 45:264–272CrossRefPubMed

Ontario Health (Quality) (2020) Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions: A health technology assessment

ORTONNE (1999) Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 140:1–7. https://doi.org/10.1046/j.1365-2133.1999.140S54001.xCrossRefPubMed

Özkan İ, Köse O, Özmen İ, Arca E (2012) Efficacy and safety of non-laser, targeted UVB phototherapy alone and in combination with psoralen gel or calcipotriol ointment in the treatment of localized, chronic, plaque-type psoriasis. Int J Dermatol 51:609–613. https://doi.org/10.1111/j.1365-4632.2011.05257.xCrossRefPubMed

Peter Kozub M (2011) Systemic therapy of psoriasis: methotrexate

Reich K, Bewley A (2011) What is new in topical therapy for psoriasis? J Eur Acad Dermatol Venereol 25:15–20CrossRefPubMed

Reichrath J, Holick MF (2018) Psoriasis and other skin diseases. In: Vitamin D. Elsevier, London, pp 1037–1051

Rendon A, Schäkel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:6CrossRef

Salman A, Yucelten AD, Sarac E et al (2018) Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study. An Bras Dermatol 93:819–823. https://doi.org/10.1590/abd1806-4841.20186981CrossRefPubMedPubMedCentral

Sandoval LF, Pierce A, Feldman SR (2014) Systemic therapies for psoriasis: an evidence-based update. Am J Clin Dermatol 15:165–180CrossRefPubMed

Sascha DMWB, Aurora G, Laura Salgado-Boquete P (2020) Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol Ther. https://doi.org/10.6084/m9.figshare.12409523

Schön MP (2019) Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front Immunol 10:1764CrossRefPubMedPubMedCentral

Shaker OG, Khairallah M, Rasheed HM et al (2013) Antiangiogenic effect of methotrexate and PUVA on psoriasis. Cell Biochem Biophys 67:735–742. https://doi.org/10.1007/s12013-013-9563-2CrossRefPubMed

Smith CH, Barker JNWN (2006) Psoriasis and its management. BMJ 333:380–384. https://doi.org/10.1136/bmj.333.7564.380CrossRefPubMedPubMedCentral

Soliman A, Nofal EA, Nofal A et al (2015) Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis. J Dermatol Treat 26:528–534. https://doi.org/10.3109/09546634.2015.1034069CrossRef

Torres AE, Lyons AB, Hamzavi IH, Lim HW (2021) Role of phototherapy in the era of biologics. J Am Acad Dermatol 84:479–485CrossRefPubMed

Torsekar R, Gautam M (2017) Topical therapies in psoriasis. Indian Dermatol Online J 8:235. https://doi.org/10.4103/2229-5178.209622CrossRefPubMedPubMedCentral

Tzaneva S, Geroldinger A, Trattner H, Tanew A (2018) Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study. Br J Dermatol 178:682–688. https://doi.org/10.1111/bjd.16106CrossRefPubMed

Uva L, Miguel D, Pinheiro C et al (2012) Mechanisms of action of topical corticosteroids in psoriasis. Int J Endocrinol 2012:561018CrossRefPubMedPubMedCentral

Valdimarsson H, Gudjonsson JE, Johnston A et al (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1–8. https://doi.org/10.1046/j.1365-2249.2004.02310.xCrossRefPubMedPubMedCentral

van Winden MEC, van der Schoot LS, van de L’Isle AM et al (2020) Effectiveness and safety of systemic therapy for psoriasis in older adults a systematic review. JAMA Dermatol 156:1229–1239CrossRefPubMed

Verallo-Rowell VM, Katalbas SS, Evangelista MTP, Dayrit JF (2018) Review update on topical therapy for psoriasis. Curr Dermatol Rep 7:24–36CrossRef

Vu TT, Koguchi-Yoshioka H, Watanabe R (2021) Skin-resident memory t cells: pathogenesis and implication for the treatment of psoriasis. J Clin Med 10:17CrossRef

Weisenseel P, Reich K, Griemberg W et al (2017) Wirksamkeit und Sicherheit von Fumarsäureestern in Kombination mit Phototherapie bei Patienten mit moderater bis schwerer Plaque-Psoriasis (FAST). JDDG-J German Soc Dermatol 15:180–186. https://doi.org/10.1111/ddg.12837CrossRef

Wong T, Hsu L, Liao W (2013a) Phototherapy in psoriasis: a review of mechanisms of action. J Cutan Med Surg 17:6–12. https://doi.org/10.2310/7750.2012.11124CrossRefPubMed

Woo W-M (2019) Imaging technologies and transdermal delivery in skin disorders. Wiley, New York

Xi C, Xiong C, Wang H et al (2021) Combination of retinoids and narrow-band ultraviolet B inhibits matrix metalloproteinase 13 expression in HaCaT keratinocytes and a mouse model of psoriasis. Sci Rep 11:13328. https://doi.org/10.1038/s41598-021-92599-wCrossRefPubMedPubMedCentral

Yélamos O, Puig L (2015) Systemic methotrexate for the treatment of psoriasis. Expert Rev Clin Immunol 11:553–563. https://doi.org/10.1586/1744666X.2015.1026894CrossRefPubMed

Zhang P, Wu MX (2018) A clinical review of phototherapy for psoriasis. Lasers Med Sci 33:173–180CrossRefPubMed

Title: Emerging trends in combination strategies with phototherapy in advanced psoriasis management
Authors: Ratnam Sreya
Shweta Nene
Vrushali Pathade
Shashi Bala Singh
Saurabh Srivastava
Publication date: 16-06-2023
Publisher: Springer International Publishing
Keywords: Phototherapy
Vulgar Psoriasis
Published in: Inflammopharmacology / Issue 4/2023
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-023-01257-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Emerging trends in combination strategies with phototherapy in advanced psoriasis management

Abstract

Graphical abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Graphical abstract

Please log in to get access to this content

Other articles of this Issue 4/2023

The NLRP3 inflammasome: role in the pathobiology of chronic pain

The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)

Pterostilbene attenuates hemin-induced dysregulation of macrophage M2 polarization via Nrf2 activation in experimental hyperglycemia

Current trends in epigenetic, cellular and molecular pathways in management of rheumatoid arthritis

Umbelliferon: a review of its pharmacology, toxicity and pharmacokinetics

The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects